MC2-03, a treatment candidate from MC2 Therapeutics, showed clinical improvement in moderate to severe dry eye patients in the phase 2 MC2-03-C1 Northern Lights trial, according to a press release.MC2-03 (PADciclo) is an eye drop containing ciclosporin…
Month: October 2018
Philips Unveils New Radiation Oncology Imaging Systems
Philips is releasing a couple new systems for radiotherapy at the American Society for Radiation Oncology’s (ASTRO) annual meeting in San Antonio, Texas. The Big Bore RT is a dedicated CT oncology simulator with built-in technologies such as iterative model reconstruction (IMR) for improved imaging of small details and for quick completion of reference protocols. […]
Corneal Transplantation Failed. What Now?
Dr Christopher Rapuano on a new study comparing long-term outcomes between penetrating and endothelial keratoplasty for repeat corneal transplantation. Medscape Ophthalmology
NeuroBlate Optic Laser Probe with Fiber Optic Temperature Control FDA Cleared
Monteris Medical, makers of the NeuroBlate MRI-guided neurosurgical laser ablation system, now has FDA clearance for its NeuroBlate Optic Laser Probe. The laser probe features cooling regulated via fiber optics and is used to attack brain tumors and epileptic foci. It also has a sapphire capsule covering the laser fiber that allows for longer engagement of the […]
Cell Care Therapeutics raises $4.3 million in funding
Cell Care Therapeutics has raised $4.3 million in seed funding from a syndicate of individual investors, the company announced in a press release.The funding will be used to develop the company’s manufacturing platform and to advance its preclinical-st…
GO2SLEEP: AI-Powered Device for Restful Sleep
The Go2Sleep Home Sleep Test is a revolutionary device on monitoring and improving your sleep quality. It elevates comfort while maintaining almost the same detecting accuracy of a pulse oximeter, but with a lot more key information. The precise data gathered would then help generate a comprehensive sleep report, just for you. Based on the […]
Samenvatting: Optos kondigt samenwerking aan voor het monitoren en behandelen van droge leeftijdsgerelateerde maculaire degeneratie in Europa
DUNFERMLINE, Schotland–(BUSINESS WIRE)–Optos Plc, een dochteronderneming van Nikon Corporation, Japan en het enige ultra-widefield retinale beeldvormingsbedrijf voor oogzorg is blij om een exclusieve distributie-overeenkomst in Europa en Australië aa…
Resumen: Optos anuncia colaboración para control y tratamiento de la degeneración macular seca asociada a la edad
DUNFERMLINE, Escocia–(BUSINESS WIRE)–Optos Plc, filial de Nikon Corporation (Japón) y la única empresa de imagen retiniana de campo de visión ultra-ancho para el tratamiento ocular ha anunciado un acuerdo de distribución exclusivo en Europa y Austral…
Oyster Point Announces Positive Results From Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye Disease
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., today announced results from the ONSET and RAINIER studies, two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED). Both stu…
VIDEO: Intraoperative Diagnostic ‘Must Haves’ for Best Refractive Cataract Surgery Outcomes
NEW YORK — From OSN New York 2018, Douglas A. Katsev, MD, of Sansum Clinic in Santa Barbara, California, gives his presentation on intraoperative diagnostic “must haves” for best refractive cataract surgery outcomes.
MC2 Therapeutics anuncia resultados de primera línea que muestran perfil de seguridad favorable y reducción de la tinción corneal para el MC2-03 en pacientes de ojo seco con queratitis moderada a severa
COPENHAGE, Dinamarca–(BUSINESS WIRE)–Regulatory News : MC2 Therapeutics A/S, una compañía dermatológica y oftalmológica de estadio clínico, ha anunciado resultados de primera línea para el estudio de fase 2 MC2-03-C1 Northern Lights que valora la seg…
Optos Announces Collaboration for Monitoring and Treating Dry Age-Related Macular Degeneration in Europe
DUNFERMLINE, Scotland–(BUSINESS WIRE)–Optos Announces Collaboration for Monitoring and Treating Dry Age-Related Macular Degeneration in Europe
CVP Partners with Two Practices in Dayton, Ohio
DENVER–(BUSINESS WIRE)–#Denver–Revelstoke Capital, a Denver-based private equity firm announces their portfolio company CEI Visions has completed two more partnerships.
Novaliq Announces Positive Topline Results for Its SEECASE Phase 2 Trial of NOV03 for the Treatment of Patients with Dry Eye Disease
HEIDELBERG, Germany–(BUSINESS WIRE)–#CyclASol–Novaliq, a specialty pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free technology for ophth…
Novaliq Announces Positive Topline Results for Its SEECASE Phase 2 Trial of NOV03 for the Treatment of Patients with Dry Eye Disease
HEIDELBERG, Germany–(BUSINESS WIRE)–#CyclASol–Novaliq, a specialty pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free technology for ophth…
Strabismus May Have Helped da Vinci Express His Genius
Intermittent exotropia may have helped artist switch from binocular to monocular vision at will and aided him in creating his works, study author explains. Medscape Medical News
FDA Warns Against Using Raindrop Near Vision Inlay
The FDA today issued an alert about an increased risk for corneal haze in patients the device after 75% of patients in a postapproval study developed haze. News Alerts
Mati Therapeutics Expands Intellectual Property Portfolio with 114 Patents Issued
AUSTIN, Texas–(BUSINESS WIRE)–Mati Therapeutics Inc. (“Mati”) announced that its international patent portfolio has grown to 114 issued patents, including recently granted U.S. Patent No. 9,849,082, titled “Nasolacrimal Drainage System Implants for D…
Interview with Deep Lens CoFounders and Pathologist User
Deep Lens Inc. is a digital pathology start-up from Ohio that exited stealth mode last week and announced $3.2 million in funding from Sierra Ventures, Rev1 Ventures, and Tamarind-Hill Fund. They’re focused on making pathology accessible by creating a platform and database of digital pathology slides that’s user friendly, informative, and powered by artificial intelligence […]
Ryan Murphy and David Miller Donate $10 Million to Children’s Hospital Los Angeles
LOS ANGELES–(BUSINESS WIRE)–On behalf of the Ford Theodore Miller Murphy Family, Emmy-Award winning writer, producer and director Ryan Murphy and his husband, photographer David Miller, have made a landmark $10 million gift to Children’s Hospital Los…